by Amy Berger | Apr 11, 2025 | News, Publications and Press
Our team is proud to share the promising news from multiple sponsors of recent IITRI in vivo studies. Links below to recent publications. Congrats all! New Sponsor Publication from Mouse Influenza Studies at IITRI: Intranasal administration of a panreactive...
by Amy Berger | Mar 5, 2025 | Events, News
Society of Toxicology 2025 is almost here! We are excited to be back for the 64th annual SOT meeting in sunny Orlando, FL in a couple of weeks! You can find us at Booth 902 near the entrance all three days of the ToxExpo from 9am – 4:30pm on March 17-19. See you...
by Amy Berger | Feb 12, 2025 | Blog, News
Per New Guidance – COVID-19 Research Now Under BSL-2, Offering Cost-Effective Solutions at IITRI We are pleased to announce that recent updates from the CDC and NIH now permit handling SARS-CoV-2 under Biosafety Level 2 (BSL-2) conditions for specific...
by Amy Berger | Feb 4, 2025 | Blog
The Importance of CRO Experience and Capabilities in Cancer Research On this World Cancer Day, we celebrate the remarkable progress made in the fight against cancer and the crucial role that contract research organizations (CROs) like IITRI play in this global effort....
by Amy Berger | Dec 10, 2024 | News, Publications and Press
Check Out Recent IITRI Mentions and Co-authored Publications Below! NPJ Vaccines Boosting neuraminidase immunity in the presence of hemagglutinin with the next generation of influenza vaccines Published Nov 19, 2024. MDPI Vaccines Intranasal M2SR and BM2SR Vaccine...
Recent Comments